Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
37.71 USD | -1.92% | -6.89% | +5.99% |
Financials (USD)
Sales 2024 * | 12.12M | Sales 2025 * | 93.57M | Capitalization | 2.85B |
---|---|---|---|---|---|
Net income 2024 * | -176M | Net income 2025 * | -143M | EV / Sales 2024 * | 165 x |
Net cash position 2024 * | 856M | Net cash position 2025 * | 665M | EV / Sales 2025 * | 23.4 x |
P/E ratio 2024 * |
-16
x | P/E ratio 2025 * |
-19.8
x | Employees | 124 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.89% |
Latest transcript on IDEAYA Biosciences, Inc.
1 day | -1.92% | ||
1 week | -6.89% | ||
Current month | -7.23% | ||
1 month | -5.58% | ||
3 months | -18.34% | ||
6 months | +17.84% | ||
Current year | +5.99% |
Managers | Title | Age | Since |
---|---|---|---|
Yujiro Hata
FOU | Founder | 49 | 15-05-31 |
Andres Briseno
DFI | Director of Finance/CFO | 38 | 16-07-31 |
Michael White
CTO | Chief Tech/Sci/R&D Officer | - | 21-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Terry Rosen
CHM | Chairman | 65 | 16-05-05 |
Wendy Yarno
BRD | Director/Board Member | 69 | 19-12-16 |
Catherine Mackey
BRD | Director/Board Member | 68 | 22-04-04 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.24% | 2 M€ | -.--% | ||
0.09% | 7 M€ | -.--% | - | |
0.07% | 0 M€ | 0.00% | - | |
0.04% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 37.71 | -1.92% | 2,126,872 |
24-05-23 | 38.45 | -7.08% | 1,002,942 |
24-05-22 | 41.38 | +0.93% | 1,284,170 |
24-05-21 | 41 | +1.69% | 1,505,818 |
Delayed Quote Nasdaq, May 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.99% | 2.85B | |
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+44.98% | 40.65B | |
-10.87% | 27.12B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B |
- Stock Market
- Equities
- IDYA Stock